The UK life sciences sector is backed by world-class science, £520 million in government commitments, and new private market infrastructure. So why is 94% of late-stage capital still coming from overseas?

Europe’s deep-tech ambitions depend on more than just research and capital, they hinge on trust, strategic collaboration, and clear communication. The European Innovation Council’s latest Corporate Startup Collaboration report shows how the EU is working to unlock growth through corporate venture capital (CVC). But to truly compete with the U.S. and Asia, Europe must go further: aligning incentives, strengthening positioning, and using strategic communications to build confidence and scale impact.